Boron-containing compounds (BCC) have emerged as important pharmacophores. To date,
five BCC drugs (including boronic acids and boroles) have been approved by the FDA for …

In this review, the history of boron's early use in drugs, and the history of the use of boron
functional groups in medicinal chemistry applications are discussed. This includes …

Abstract 2D transition metal borides (MBenes) have emerged as promising post‐MXene
materials with potential application in various biotechnological fields. Although they possess …

1. INTRODUCTION Benzoxaboroles, first obtained by Torssell in 1957, 1 remained
underestimated for a long time. The new beginning for these remarkable compounds took …

Covalent enzyme inhibitors are widely applied as biochemical tools and therapeutic agents.
As a complement to categorization of these inhibitors by reactive group or modification site …

Boron-containing compounds which possess unique and attractive properties have received
increasing attention from the pharmaceutical industry and academia recently. They have …

We demonstrate here, for the first time, formation of injectable dynamic covalent hydrogels at
physiological pH using benzoxaborin-saccharide complexation as a reversible cross-linking …

Boron was misconstrued as a toxic element for animals, which retarded the growth of boron-
containing drug discovery in the last century. Nevertheless, modern applications of boronic …

Introduction: Benzoxaborole is a versatile boron-heterocyclic scaffold which has found in the
last 10 years a broad spectrum of applications in medicinal chemistry, due to its …

Despite their desirable attributes, boronic acids have had a minimal impact in biological
contexts. A significant problem has been their oxidative instability. At physiological pH …